2.
Peel the strips.
3.
Open thesachet.
4.
Remove the patch from the sachet.
5.
The adhesive side of the patch is covered by a disposable transparent cover.
6.
7.
8.
9.
Double the other half of the patch back and remove the rest of the disposable cover.
10.
This way you ensure that the patch is in contact with the skin and the edges are well attached.
11.
Wash your hands with water and soap immediately after handling the patch.
How to remove the used patch
If you use more Neupro than you should
Using higher doses of Neupro than your doctor has indicated can cause side effects such as nausea or vomiting, decreased blood pressure, seeing or hearing things that are not real (hallucinations), confusion, extreme drowsiness, involuntary movements, and seizures.
Report this to your doctor or go to the hospital as soon as possible. They will tell you what to do.
If you forgot to change the patch at your usual time
In both cases, the next day put on a new one at the usual time. Do not use a double dose to make up for the missed doses.
If you interrupt treatment withNeupro
Do not stop using Neupro without first consulting your doctor. Sudden interruption could cause a condition called ‘neuroleptic malignant syndrome’ that can put your life at risk. The signs include: loss of muscle movement (akinesia), muscle rigidity, fever, unstable blood pressure, increased heart rate (tachycardia), confusion, decreased consciousness (e.g. coma).
If your doctor tells you to stop treatment with Neupro, thedaily doseof Neupro should begradually reduced:
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. Inform your doctor, pharmacist, or nurse if you notice any side effects.
Most likely side effects at the start of treatment
You may experiencenauseaandvomitingat the start of treatment. These side effects are usually mild or moderate and do not last long. You shouldconsult your doctorif the side effects last a long time or if they concern you.
Skin problems caused by the patch
You may experience loss of consciousness
Neupro can cause loss of consciousness. This can happen especially when you start treatment with Neupro or when your dose is increased. Inform your doctor if you lose consciousness or feel dizzy.
Changes in behavior and abnormal thoughts
Inform your doctor if you notice any change in behavior, thought, or both, as indicated below.
Your doctor will tell you how to manage or reduce the symptoms.
If your family or caregiver, or your doctor, are concerned about changes in your behavior, it may be helpful to tell a family member or caregiver that you are using this medicine and have them read this leaflet. Neupro can cause anxiety or an urgent need to behave in an unusual way and not be able to control the impulse, attack, or temptation to perform certain actions that may harm you or others.
These actions may include:
Neupro can cause other abnormal behaviors and thoughts, which may include:
Inform your doctor if you notice any change in your behavior, thought, or both, as indicated above.
Your doctor will tell you how to manage or reduce the symptoms.
Allergic reactions
Inform your doctor if you notice signs of an allergic reaction – which may include swelling of the face, tongue, or lips.
Side effects if using Neupro for Restless Legs Syndrome
Inform your doctor or pharmacist if you experience any of the following side effects:
Very common: may affect more than 1 in 10 patients
Frequent: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Rare: may affectup to 1 in 1,000 patients
Unknown:not known how often they occur
Inform your doctor or pharmacist if you experience any of these side effects.
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational reporting system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label and on the carton box.
Do not store above 86°F (30°C).
What to do with used and unused patches
Composition ofNeupro
The active ingredient is rotigotine.
A patch releases 1 mg of rotigotine every 24 hours. Each patch of 5 cm2 contains 2.25 mg of rotigotine.
A patch releases 3 mg of rotigotine every 24 hours. Each patch of 15 cm2 contains 6.75 mg of rotigotine.
The other components are:
Appearance of the product and contents of the package
Neupro is a transdermal patch. It is thin and has three layers. It has a square shape with rounded corners. The outer part is brown and has the imprint Neupro 1 mg/24 h or 3 mg/24 h.
Neupro is available in the following formats:
Carton packs containing 7, 14, 28, 30 or 84 (multi-pack containing 3 packs of 28) patches, each patch is included in an individual sachet.
Only some package sizes may be marketed.
Marketing Authorization Holder
UCB Pharma S.A.
Allée de la Recherche 60
B-1070 Brussels
Belgium
Responsible for manufacturing
UCB Pharma S.A.
Chemin du Foriest
B-1420 Braine l’Alleud
Belgium
For more information about this medicine, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien UCB Pharma SA/NV Tel/Tel: +32-(0)2 559 92 00 | Lietuva UCB Pharma Oy Finland Tel: +358-92 514 4221 (Suomija) |
Luxembourg/Luxemburg UCB Pharma SA/NV Tél/Tel: +32-(0)2 559 92 00 | |
Ceská republika UCB s.r.o. Tel: +420-221 773 411 | Magyarország UCB Magyarország Kft. Tel.: +36-(1) 391 0060 |
Danmark UCB Nordic A/S Tlf.: +45-32 46 24 00 | Malta Pharmasud Ltd. Tel: +356-21 37 64 36 |
Deutschland UCB Pharma GmbH Tel: +49-(0) 2173 48 48 48 | Nederland UCB Pharma B.V. Tel: +31-(0)76-573 11 40 |
Eesti UCB Pharma Oy Finland Tel: +358-92 514 4221 (Soome) | Norge UCB Nordic A/S Tlf: +45-32 46 24 00 |
Ελλ?δα UCBΑ.Ε. Τηλ: +30-2109974000 | Österreich UCB Pharma GmbH Tel: + 43-(0)1 291 80 00 |
España UCB Pharma S.A. Tel: +34-91 570 34 44 | Polska UCB Pharma Sp. z o.o. Tel.: +48-22 696 99 20 |
France UCB Pharma S.A. Tél: +33-(0)1 47 29 44 35 Hrvatska MedisAdria d.o.o. Tel: +385-(0)1 230 34 46 | Portugal BIAL-Portela & Cª, S.A. Tel: +351-22 986 61 00 România UCB Pharma România S.R.L. Tel: +40-21 300 29 04 |
Ireland UCB (Pharma) Ireland Ltd. Tel: +353-(0)1-46 37 395 | Slovenija Medis, d.o.o. Tel: +386-1 589 69 00 |
Ísland Vistor hf. Sími:+354-535 7000 | Slovenská republika UCB s.r.o., organizacná zložka Tel: +421-(0)2 5920 2020 |
Italia UCB Pharma S.p.A. Tel: +39-02 300 791 | Suomi/Finland UCB Pharma Oy Finland Puh/Tel: +358-92 514 4221 |
Κ?προς Lifepharma (Z.A.M.)Ltd Τηλ: +357-22 34 74 40 | Sverige UCB Nordic A/S Tel: +46-(0)40 29 4900 |
Latvija UCB Pharma Oy Finland Tel: +358-92 514 4221 (Somija) | |
Last update of this leaflet:
Other sources of information
The detailed information about this medicine is available on the website of the European Medicines Agencyhttps://www.ema.europa.eu
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.